Matrix metalloproteinase-8 inhibitors mitigate sepsis-induced myocardial injury in rats

Xiaorui Zhou1, Jiakai Lu2, Dong Chen3

  • 1Beijing Institute of Heart, Lung and Blood Vessel Diseases, Department of Surgical Intensive Care Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Abstract

Insights

Metalloproteinase-8 (MMP-8) inhibition reduced sepsis-induced myocardial injury in rats. This protective effect may stem from decreased levels of inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β).

Area of Science:

  • Cardiology
  • Pathophysiology
  • Pharmacology

Background:

  • Sepsis-induced myocardial injury (SIMI) involves complex mechanisms.
  • Metalloproteinase-8 (MMP-8) is implicated in SIMI pathogenesis.

Purpose of the Study:

  • To investigate the effects of MMP-8 on SIMI in a rat model.
  • To elucidate the underlying mechanisms of MMP-8's role in SIMI.

Main Methods:

  • A cecal ligation and puncture (CLP) model was used to induce sepsis in male Sprague Dawley rats.
  • Rats were treated with an MMP-8 inhibitor (M8I) or dexamethasone (DEX).
  • Myocardial injury, MMP-8, TNF-α, and IL-1β levels were assessed via histology, Western blotting, and ELISA.

Main Results:

  • Sepsis led to significant myocardial injury, with elevated MMP-8, TNF-α, and IL-1β expression.
  • M8I and DEX treatments attenuated cardiac histopathological damage and reduced serum/myocardial TNF-α and IL-1β levels.
  • M8I significantly decreased myocardial MMP-8 expression, while DEX did not affect MMP-8 levels.

Conclusions:

  • MMP-8 inhibition ameliorated myocardial injury in septic rats.
  • Reduced expression of TNF-α and IL-1β may mediate the protective effects of MMP-8 inhibition in SIMI.

Related Concept Videos